Netrin receptor functions have been implicated in tumorigenic processes such as angiogenesis [42,43], apoptosis, and cell invasion [44–46], thus suggesting UNC-5 or UNC-40/DCC as targets for cancer therapy that might be less deleterious to normal cells than targeting small GTPases. The gene discussed is DCC; the disease is cancer.